Renal Dysfunction After Liver Transplant: Is CNI Nephrotoxicity Overrated.
作者信息
Puri Pankaj, Bansal Nalini
机构信息
Fortis Escorts Liver and Digestive Diseases Institute, Fortis Escorts Hospital, New Delhi, 110025, India.
Institute of Gastro and Hepato Pathology, Gurgaon, Haryana, 122003, India.
出版信息
J Clin Exp Hepatol. 2023 Jul-Aug;13(4):556-558. doi: 10.1016/j.jceh.2023.05.005. Epub 2023 May 19.
Abstract
摘要
相似文献
1
Renal Dysfunction After Liver Transplant: Is CNI Nephrotoxicity Overrated.肝移植后的肾功能障碍：钙调神经磷酸酶抑制剂的肾毒性是否被高估了。
J Clin Exp Hepatol. 2023 Jul-Aug;13(4):556-558. doi: 10.1016/j.jceh.2023.05.005. Epub 2023 May 19.
2
Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent.在肝移植患者中，使用雷帕霉素作为主要免疫抑制剂可逆转钙调神经磷酸酶抑制剂诱导的慢性肾毒性。
Clin Transplant. 2002;16 Suppl 7:49-51. doi: 10.1034/j.1399-0012.16.s7.7.x.
3
Long-term renal function deteriorates at a similar rate among liver transplant patients with preserved renal function at 1 year and in the general population: is chronic calcineurin inhibitor nephrotoxicity overrated?
Transplant Proc. 2013 Apr;45(3):1182-7. doi: 10.1016/j.transproceed.2012.10.015.
4
Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.儿童实体器官移植受者中钙调神经磷酸酶抑制剂诱导的肾毒性的治疗策略。
Pediatr Transplant. 2006 Sep;10(6):721-9. doi: 10.1111/j.1399-3046.2006.00577.x.
5
Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.西罗莫司为基础的免疫抑制治疗用于患有他克莫司相关慢性肾功能不全的肝移植受者。
Transplant Proc. 2008 Jun;40(5):1541-4. doi: 10.1016/j.transproceed.2008.01.081.
6
Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction.在患有慢性肾功能不全的肝移植患者中，降低钙调神经磷酸酶抑制剂剂量联合霉酚酸酯的疗效和安全性。
Oncotarget. 2017 Feb 18;8(34):57505-57515. doi: 10.18632/oncotarget.15490. eCollection 2017 Aug 22.
7
Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.钙调磷酸酶抑制剂肾毒性：证据的综述和展望。
Am J Nephrol. 2013;37(6):602-12. doi: 10.1159/000351648. Epub 2013 Jun 18.
8
Acute Calcineurin Inhibitor Nephrotoxicity Diagnosed Using Kidney Doppler Ultrasonography After Heart Transplant: A Case Report.
Transplant Proc. 2022 Dec;54(10):2722-2726. doi: 10.1016/j.transproceed.2022.10.027. Epub 2022 Nov 16.
9
Limitations of current liver transplant immunosuppressive regimens: renal considerations.当前肝移植免疫抑制方案的局限性：肾脏方面的考量
Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):27-32. doi: 10.1016/s1499-3872(16)60167-4.
10
SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity.基于西罗莫司的免疫抑制与慢性钙调神经磷酸酶抑制剂肾毒性的小儿肾移植受者中钙调神经磷酸酶抑制剂最小化的比较
Pediatr Transplant. 2006 Aug;10(5):593-601. doi: 10.1111/j.1399-3046.2006.00526.x.
引用本文的文献
1
Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?肾移植中的调节性T细胞：细胞治疗的未来？
Antibodies (Basel). 2025 Jun 17;14(2):49. doi: 10.3390/antib14020049.
本文引用的文献
1
The Renal Histological Correlates of Refractory Renal Dysfunction After Liver Transplantation.肝移植后难治性肾功能障碍的肾脏组织学关联
J Clin Exp Hepatol. 2023 Jul-Aug;13(4):586-591. doi: 10.1016/j.jceh.2023.01.010. Epub 2023 Jan 30.
2
Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity.他克莫司：用于成人肾移植20年。我们应该了解的关于其肾毒性的知识。
Artif Organs. 2020 Feb;44(2):140-152. doi: 10.1111/aor.13551. Epub 2019 Sep 4.
3
Key role of renal biopsy in management of progressive chronic kidney disease in liver graft recipients.肾活检在肝移植受者进行性慢性肾脏病治疗中的关键作用。
J Nephrol. 2019 Feb;32(1):129-137. doi: 10.1007/s40620-018-0506-2. Epub 2018 Jun 26.
4
Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment.肝移植受者肾功能损害时行肾活检的临床价值。
Kidney Res Clin Pract. 2013 Dec;32(4):153-7. doi: 10.1016/j.krcp.2013.08.002. Epub 2013 Oct 24.
5
The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors.钙调神经磷酸酶抑制剂过度夸大的慢性肾毒性。
Arab J Urol. 2012 Jun;10(2):169-74. doi: 10.1016/j.aju.2012.02.003. Epub 2012 Apr 7.
6
Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate.肝移植后慢性肾脏病及相关死亡率——一项使用实测肾小球滤过率的时间依赖性分析
J Hepatol. 2014 Aug;61(2):286-92. doi: 10.1016/j.jhep.2014.03.034. Epub 2014 Apr 5.
7
Renal dysfunction in liver transplant recipients: evaluation of the critical issues.肝移植受者的肾功能障碍：关键问题评估。
Liver Transpl. 2012 Nov;18(11):1290-301. doi: 10.1002/lt.23522. Epub 2012 Oct 8.
8
Tacrolimus-induced nephrotoxicity and genetic variability: a review.他克莫司诱导的肾毒性与基因变异性：综述
Ann Transplant. 2012 Apr-Jun;17(2):111-21. doi: 10.12659/aot.883229.
9
Renal comorbidity after solid organ and stem cell transplantation.实体器官和干细胞移植后的肾脏合并症。
Am J Transplant. 2012 Jul;12(7):1691-9. doi: 10.1111/j.1600-6143.2012.04047.x. Epub 2012 Apr 9.
10
Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.低剂量环孢素治疗的肾移植受者中慢性 CNI 肾毒性的组织学标志物的特异性。
Am J Transplant. 2011 Dec;11(12):2635-46. doi: 10.1111/j.1600-6143.2011.03718.x. Epub 2011 Aug 30.
Zotero 插件